ASMB — Assembly Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for Assembly Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	274	216	147	91.6	130
Net Total Accounts Receivable
Net Total Receivables	3.37	1.23	0.336	0.944	0.043
Prepaid Expenses
Total Current Assets	283	224	154	97	134
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13.8	10.7	7.18	3.94	2.72
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	340	283	191	102	137
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	24.4	24.4	16.1	16.3	39.2
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	66.7	42.7	22.1	19.1	95.7
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	273	241	169	82.7	41.1
Total Liabilities & Shareholders' Equity	340	283	191	102	137
Total Common Shares Outstanding
Total Preferred Shares Outstanding